Phase 3 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children aged 2 years up to (but not including) 18 years old at the time of consent
- People with low iron levels in their blood, shown by either a haemoglobin level below 12.0 g/dL combined with low iron stores, or those considered at risk of developing low iron levels based on specific blood test results and a recent history of low haemoglobin
- People with chronic kidney disease, which may include those on regular haemodialysis, those on peritoneal dialysis, those with reduced kidney function based on a specific blood test result, or those with signs of lasting kidney damage shown by urine or blood tests lasting more than 3 months
- For children not on haemodialysis: those who have previously tried iron tablets without success, could not tolerate iron tablets, or whose doctor considers iron tablets medically unsuitable for them
- Those of childbearing potential who are sexually active must have been using an effective form of contraception for at least one month before the trial starts and agree to continue using it for the duration of the trial
Who may not be able to join:
- Those with a known allergic reaction to ferumoxytol or iron sucrose (the medicines used in the trial)
- Those with a history of an allergic reaction to any iron given through a drip (intravenous iron)
- Those with a history of allergies to more than two different medications
- Those with low blood pressure for their age group (confirm with trial site for exact thresholds)
- Those with a haemoglobin level at or below 7.0 g/dL (very low red blood cell levels)
- Those with a high ferritin level above 600 ng/mL (indicating already high iron stores in the body)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-374 -4177
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hemoglobin change of at least 0.5 g/dL from Baseline to Week 5
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.